Skip to main content

Thiamine (Vitamin B1)

Thiamine (vitamin B1) is a water-soluble B vitamin that serves as an essential cofactor for energy metabolism, neurotransmitter synthesis, and myelin maintenance, functioning primarily through its active form, thiamine pyrophosphate (TPP).[1][2][3] It is a cofactor for > 24 enzymes, including three critical enzyme complexes: pyruvate dehydrogenase (linking glycolysis to the Krebs cycle), α-ketoglutarate dehydrogenase (within the Krebs cycle), and transketolase (in the pentose phosphate pathway).[3][4] Deficiency leads to impaired oxidative metabolism, lactic acidosis, and selective vulnerability of metabolically active tissues — particularly the brain and heart.[2][5]

For the reconstructive urologist and urogynecologist, thiamine carries one universal high-yield rule and four specific reconstructive scenarios. The universal rule: always give thiamine before glucose in any post-bariatric, alcohol-using, hyperemetic, or chronically malnourished patient with altered mental status — carbohydrate loading in a depleted patient acutely consumes residual thiamine and can precipitate Wernicke encephalopathy within hours. The four scenarios are post-bariatric reconstruction, refeeding syndrome, hyperemesis gravidarum, and chronic loop-diuretic users facing major reconstruction.

Biochemistry and Metabolism​

After active absorption by specialized thiamine transporters in the jejunum and ileum, free thiamine is phosphorylated to TPP, which catalyzes key steps in carbohydrate, lipid, and branched-chain amino acid metabolism.[1]

Three critical metabolic outputs depend on TPP:[3][5]

  • Energy production — TPP is required for pyruvate dehydrogenase (pyruvate → acetyl-CoA) and α-ketoglutarate dehydrogenase (α-ketoglutarate → succinyl-CoA) in the Krebs cycle, generating ATP. In deficiency, pyruvate and lactate accumulate, causing lactic acidosis.[1][5]
  • Nucleotide and NADPH synthesis — Transketolase in the pentose phosphate pathway requires TPP to generate ribose-5-phosphate (for DNA / RNA synthesis) and NADPH (for antioxidant defense and biosynthetic reactions).[3][5]
  • Neurotransmitter and myelin synthesis — TPP indirectly supports synthesis of acetylcholine, serotonin, GABA, and glutamate, as well as myelin maintenance, by providing the energy and precursors these processes require.[3]

Body stores of thiamine are limited to 30–50 mg, and complete depletion can occur within 2–4 weeks of inadequate intake — making it one of the fastest vitamins to become deficient.[4][5] Clinical symptoms can appear as early as 1 week after thiamine depletion.[4]

Dietary Sources and Requirements​

Thiamine is found in whole grains, legumes, nuts, seeds, pork, eggs, dairy, and fortified cereals.[1] The RDA for adults is approximately 1.1–1.2 mg/day, with higher requirements with carbohydrate-heavy intake, pregnancy, lactation, and hyperthyroidism.[6][5] No UL has been established — excess thiamine is readily excreted renally and toxicity is extremely rare.[2]

Assessment of Thiamine Status​

  • Erythrocyte thiamine pyrophosphate (TPP) — Preferred direct biomarker; measures the active coenzyme form in red cells. Low levels confirm deficiency.[1][7]
  • Erythrocyte transketolase activity coefficient (ETKAC) — Functional assay measuring TPP-dependent enzyme activation. ETKAC > 25% (i.e., > 25% increase in transketolase activity after TPP addition) suggests deficiency. Used for > 50 years but lacks standardized cutoffs.[8][9]
  • Serum thiamine — Not a reliable marker of total body stores; may be normal despite tissue depletion.[1]
  • Clinical response to thiamine — In practice, the diagnosis is often confirmed by clinical improvement after parenteral thiamine administration, particularly in suspected Wernicke encephalopathy.[10][11]

Causes of Deficiency​

CategoryExamples
Poor intakeAlcohol use disorder, polished rice / refined-grain diets, anorexia nervosa, prolonged fasting, TPN without supplementation
MalabsorptionChronic alcoholism, bariatric surgery (RYGB, SG, BPD/DS), IBD, chronic diarrhea
Increased lossesLoop diuretics (urinary excretion), renal replacement therapy, excessive vomiting (hyperemesis gravidarum)
Increased demandRefeeding syndrome, pregnancy, lactation, hyperthyroidism, sepsis, critical illness
Impaired conversionAlcohol inhibits phosphorylation of thiamine to TPP; magnesium deficiency impairs transketolase function

Alcohol use disorder is the most common cause in developed countries, operating through poor intake, impaired absorption, decreased hepatic storage, impaired phosphorylation to TPP, and increased metabolic demand.[1][12]

Bariatric surgery — A meta-analysis found that 27% of patients develop thiamine deficiency, with prevalence peaking at 19% at 3 months postoperatively.[13][14] AACE/TOS/ASMBS 2019 guidelines recommend all post-bariatric patients take at least 12 mg of thiamine daily, with 50–100 mg daily for high-risk patients.[15]

Clinical Manifestations​

Thiamine deficiency produces three major clinical syndromes, frequently overlapping:[1][4]

Dry Beriberi (Neurologic)​

Symmetric, length-dependent axonal sensorimotor polyneuropathy affecting the lower extremities first, with burning dysesthesias, weakness, and areflexia. May also present as polyradiculoneuropathy mimicking Guillain-Barré syndrome, or involve cranial nerves (II, III, IV, VI, VII, VIII, IX, X).[4][16]

Wet Beriberi (Cardiovascular)​

High-output heart failure with peripheral vasodilation, tachycardia, peripheral edema, elevated JVP, and cardiomegaly. Initial high-output state progresses to myocardial depression and low-output failure.[1][7] Shoshin beriberi is the fulminant form with acute cardiovascular collapse, lactic acidosis, and high mortality without emergent thiamine replacement.[4]

Wernicke-Korsakoff Syndrome (Neuropsychiatric)​

The most clinically important manifestation in developed countries:

  • Wernicke encephalopathy (WE) — Acute, potentially reversible neurologic emergency defined by the classic triad of mental status changes, oculomotor dysfunction (nystagmus, ophthalmoplegia), and gait ataxia. The complete triad is present in fewer than 10–33% of cases; most patients present with delirium or confusion alone. Caine criteria (requiring ≥ 2 of: dietary deficiency, oculomotor abnormalities, cerebellar dysfunction, altered mental status / mild memory impairment) improve diagnostic sensitivity.[12][10][17][18]
  • Korsakoff syndrome — Develops in approximately 80% of untreated WE cases; characterized by irreversible anterograde and retrograde amnesia with confabulation, from permanent damage to the diencephalon-hippocampal circuit (mammillary bodies, medial thalamus).[12][4]

Autopsy studies report WE prevalence of 0.4–2.8%, with the majority undiagnosed during life — underscoring the critical importance of clinical suspicion.[18]

MRI in Wernicke Encephalopathy​

MRI is the most valuable confirmatory tool, with sensitivity 53% but specificity 93%.[19] Typical findings: bilateral, symmetric T2 / FLAIR hyperintensities in the:[19][20][5]

  • Medial thalami (most common)
  • Mammillary bodies
  • Periaqueductal gray matter
  • Tectal plate
  • Floor of the fourth ventricle
  • Midline cerebellum

Atypical sites (corpus callosum splenium, fornix, cerebral cortex, cerebellar vermis) appear in more severe cases and correlate with lower blood thiamine levels.[20] DWI shows restricted diffusion consistent with reversible cytotoxic edema, which resolves with prompt thiamine treatment.[19][21]

Treatment of Thiamine Deficiency​

Wernicke Encephalopathy (Acute)​

  • ASPEN position paper — 500 mg IV thiamine hydrochloride three times daily for 2–3 days, followed by 250 mg IV / IM daily for 3–5 days.[8]
  • 2026 JAMA review — 100–200 mg IV three times daily for 3 days, followed by long-term oral supplementation of 100 mg daily.[16]
  • ASAM recommends routine thiamine supplementation as preventive measure for all patients in alcohol withdrawal.[12]
  • Thiamine must be given BEFORE glucose — carbohydrate loading consumes thiamine as a cofactor and can precipitate or worsen WE in depleted patients.[16][12]
  • Magnesium must be repleted — magnesium is a cofactor for thiamine phosphorylation and transketolase function; patients with hypomagnesemia may fail to respond to thiamine alone.[11][8]

Prophylaxis in High-Risk Patients​

  • 100 mg oral thiamine daily for individuals with malnutrition or alcohol use disorder.[16]
  • Post-bariatric surgery — At least 12 mg daily, with 50–100 mg daily for high-risk patients.[15]

Wet Beriberi / Cardiac​

  • 200 mg IV or oral thiamine three times daily until symptoms resolve, then 10 mg/day oral until full recovery. Symptoms, cardiomegaly, and impaired LVEF typically resolve with treatment.[1]

Thiamine in Heart Failure​

Thiamine deficiency is not only a cause of heart failure (wet beriberi) but is also prevalent among patients with established HF, particularly those on loop diuretics (which increase urinary thiamine excretion).[1][22] Prevalence of B-vitamin deficiency in HF patients has been reported as high as 68%.[22]

However, evidence for routine supplementation in HF patients without clinical deficiency is negative. A meta-analysis of 8 RCTs (384 patients) found no significant improvement in LVEF, NYHA class, BNP, or quality of life.[23] The largest individual RCT (Keith 2019) found no benefit in LVEF, exercise capacity, or quality of life over 6 months despite increased thiamine levels.[24] The AHA 2023 Scientific Statement concludes that thiamine supplementation in HF patients without clinically significant deficiency may not be efficacious and should be avoided.[25]

Thiamine in Sepsis and Critical Illness​

Thiamine deficiency has been reported in approximately 20% of critically ill patients with sepsis.[26] Interest in the "metabolic resuscitation" cocktail (vitamin C + hydrocortisone + thiamine) was sparked by a 2017 observational study, but subsequent large RCTs have been negative:

  • VITAMINS (2020, JAMA) — Vitamin C + hydrocortisone + thiamine vs hydrocortisone alone (n = 216 septic shock): no difference in vasopressor-free time or 90-day mortality.[26]
  • ACTS (2020, JAMA) — Vitamin C + corticosteroids + thiamine vs placebo (n = 501): no improvement in SOFA at 72 h or 30-day mortality.[27]
  • VICTAS (2021, JAMA) — Vitamin C + thiamine + hydrocortisone vs placebo (n = 501): no difference in ventilator- and vasopressor-free days.[28]

A retrospective study did find thiamine administration within 24 hours of septic shock admission associated with improved lactate clearance and reduced 28-day mortality, but this was observational.[29]

Refeeding Syndrome​

Thiamine plays a critical role in refeeding syndrome, a potentially fatal complication of nutritional rehabilitation in malnourished patients. When carbohydrate feeding is resumed, the sudden increase in glucose metabolism rapidly consumes remaining thiamine stores, precipitating acute deficiency. Thiamine supplementation should be initiated before or simultaneously with caloric repletion in all at-risk patients.[1][11][30]

Reconstructive Relevance​

0. The Universal Rule — Thiamine Before Glucose​

In any patient with the following profile presenting with altered mental status, ataxia, ophthalmoplegia, or unexplained postoperative confusion, give empiric IV thiamine BEFORE administering glucose-containing fluids:

  • Post-bariatric surgery (especially RYGB, SG with persistent vomiting, BPD/DS) — any time in the first year, peak risk 2–4 months post-op.
  • Chronic alcohol use disorder.
  • Hyperemesis gravidarum or significant postoperative emesis.
  • Prolonged NPO > 1 week (radiation enteritis, post-cystectomy ileus, fistula management, ICU stay).
  • Anorexia nervosa or significant unintentional weight loss.

A single 100 mg IV thiamine dose carries virtually no toxicity risk and can prevent permanent Korsakoff amnesia. Do not wait for laboratory confirmation.

1. Post-Bariatric Patients Undergoing Later Reconstruction​

This is the most common reconstructive setting in which thiamine matters. A patient who had RYGB / SG / BPD-DS and is now presenting for urethroplasty, urinary diversion, GAS, complex prolapse, or other elective reconstruction may carry subclinical thiamine deficiency:

  • Verify thiamine supplementation status preoperatively (12 mg/d minimum; 50–100 mg/d if high-risk per ASMBS 2019).
  • Postoperative emesis in this population is a thiamine-depletion red flag — give empiric IV thiamine, not just antiemetics.
  • Avoid carbohydrate-only IVF in the first 24 h if there's any preexisting deficiency suspicion.

2. Refeeding Syndrome Prevention​

Reconstructive scenarios with high refeeding-syndrome risk:

  • Post-cystectomy / ileal-conduit / neobladder with prolonged ileus (> 7 days NPO + minimal intake).
  • Enterocutaneous fistula management with extended bowel rest.
  • Radiation enteritis survivors with chronic intermittent NPO cycles.
  • Severe pelvic-cancer survivors post-exenteration with chronic nutritional compromise.

Always give thiamine 100 mg IV before initiating TPN or aggressive enteral feeding in any patient with prolonged NPO or significant weight loss. Continue 100 mg daily for the first 3–7 days of refeeding alongside phosphate, magnesium, and potassium monitoring. See Perioperative Nutrition.

3. Hyperemesis Gravidarum in Reproductive-Age Urogyn Patients​

Pregnant patients with hyperemesis develop thiamine deficiency rapidly (stores depleted in 2–4 weeks) and are at risk of Wernicke encephalopathy in pregnancy — a recognized devastating complication. For the urogyn patient with a recent or current hyperemesis history facing reconstruction:

  • Check thiamine status if any vomiting in the prior month.
  • Empiric IV thiamine 100 mg before any IVF with dextrose in the hyperemetic patient.
  • Continue oral supplementation through resolution.

4. Chronic Loop-Diuretic Users Facing Reconstruction​

Patients on chronic furosemide, torsemide, or bumetanide (heart failure, CKD, cirrhosis) lose thiamine urinarily. For these patients undergoing major elective reconstruction:

  • Screen for deficiency preoperatively (erythrocyte TPP or clinical assessment).
  • Supplement at the perioperative interval, but do not initiate routine supplementation in HF patients without measured deficiency (AHA 2023 — no benefit, possible harm).
  • Recheck magnesium — concurrent hypomagnesemia must be corrected for thiamine to work.

5. Trauma Reconstruction in Patients with Alcohol Use Disorder​

For the trauma patient with chronic alcohol use undergoing reconstruction (PFUI urethroplasty, bladder-trauma repair, perineal reconstruction after pelvic fracture):

  • Universal preoperative thiamine (100 mg IV) as soon as encounter begins, regardless of mental status.
  • Continue per ASAM withdrawal protocol throughout admission.
  • Magnesium repletion is essential.

See Also​

References​

1. Sliwa K, Viljoen CA, Hasan B, Ntusi NAB. "Nutritional Heart Disease And Cardiomyopathies: JACC Focus Seminar 4/4." Journal of the American College of Cardiology. 2022. doi:10.1016/j.jacc.2022.08.812

2. Mrowicka M, Mrowicki J, Dragan G, Majsterek I. "The Importance of Thiamine (Vitamin B1) in Humans." Bioscience Reports. 2023;43(10):BSR20230374. doi:10.1042/BSR20230374

3. Calderón-Ospina CA, Nava-Mesa MO. "B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin." CNS Neuroscience & Therapeutics. 2020;26(1):5–13. doi:10.1111/cns.13207

4. Gwathmey KG, Grogan J. "Nutritional neuropathies." Muscle & Nerve. 2020;62(1):13–29. doi:10.1002/mus.26783

5. Manzo G, De Gennaro A, Cozzolino A, et al. "MR Imaging Findings in Alcoholic and Nonalcoholic Acute Wernicke's Encephalopathy: A Review." BioMed Research International. 2014;2014:503596. doi:10.1155/2014/503596

6. Allen LH. "Micronutrients — Assessment, Requirements, Deficiencies, and Interventions." The New England Journal of Medicine. 2025;392(10):1006–1016. doi:10.1056/NEJMra2314150

7. Lipshultz SE, Law YM, Asante-Korang A, et al. "Cardiomyopathy in Children: Classification and Diagnosis — AHA Scientific Statement." Circulation. 2019;140(1):e9–e68. doi:10.1161/CIR.0000000000000682

8. Vanek VW, Borum P, Buchman A, et al. "ASPEN Position Paper: Recommendations for Changes in Commercially Available Parenteral Multivitamin and Multi-Trace Element Products." Nutrition in Clinical Practice. 2012;27(4):440–491. doi:10.1177/0884533612446706

9. Jones KS, Parkington DA, Cox LJ, Koulman A. "Erythrocyte Transketolase Activity Coefficient (ETKAC) Assay Protocol for the Assessment of Thiamine Status." Annals of the New York Academy of Sciences. 2021;1498(1):77–84. doi:10.1111/nyas.14547

10. Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. "Wernicke Encephalopathy — Clinical Pearls." Mayo Clinic Proceedings. 2019;94(6):1065–1072. doi:10.1016/j.mayocp.2019.02.018

11. Wijnia JW. "A Clinician's View of Wernicke-Korsakoff Syndrome." Journal of Clinical Medicine. 2022;11(22):6755. doi:10.3390/jcm11226755

12. American Society of Addiction Medicine. "Clinical Practice Guideline on Alcohol Withdrawal Management." 2020.

13. Bahardoust M, Eghbali F, Shahmiri SS, et al. "B1 Vitamin Deficiency After Bariatric Surgery, Prevalence, and Symptoms: A Systematic Review and Meta-Analysis." Obesity Surgery. 2022;32(9):3104–3112. doi:10.1007/s11695-022-06178-7

14. Karimi Behnagh A, Eghbali M, Abdolmaleki F, Abbasi M, Mottaghi A. "Pre- And Post-Surgical Prevalence of Thiamine Deficiency in Patients Undergoing Bariatric Surgery: A Systematic Review and Meta-Analysis." Obesity Surgery. 2024;34(2):653–665. doi:10.1007/s11695-023-06896-6

15. Mechanick JI, Apovian C, Brethauer S, et al. "Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures — 2019 Update." Obesity. 2020;28(4):O1–O58. doi:10.1002/oby.22719

16. Mauermann ML, Staff NP. "Peripheral Neuropathy." JAMA. 2026;335(3):255–266. doi:10.1001/jama.2025.19400

17. Li Z, Min Q, Chen J, et al. "Dynamic Progression of Wernicke Encephalopathy in a Gastric Cancer Patient: Multimodal MRI Insights With Arterial Spin Labeling Perfusion Imaging." Medicine. 2025;104(32):e43580. doi:10.1097/MD.0000000000043580

18. Li S, Xing C. "Wernicke Encephalopathy: A Mini Review of the Clinical Spectrum, Atypical Manifestations, and Diagnostic Challenges." Frontiers in Neurology. 2025;16:1566366. doi:10.3389/fneur.2025.1566366

19. Sechi G, Serra A. "Wernicke's Encephalopathy: New Clinical Settings and Recent Advances in Diagnosis and Management." The Lancet Neurology. 2007;6(5):442–455. doi:10.1016/S1474-4422(07)70104-7

20. Hiraga A, Kojima K, Kuwabara S. "Typical and Atypical MRI Abnormalities in Wernicke's Encephalopathy: Correlation With Blood Vitamin B1 Levels." Journal of the Neurological Sciences. 2024;461:123045. doi:10.1016/j.jns.2024.123045

21. Chu K, Kang DW, Kim HJ, Lee YS, Park SH. "Diffusion-Weighted Imaging Abnormalities in Wernicke Encephalopathy: Reversible Cytotoxic Edema?" Archives of Neurology. 2002;59(1):123–127. doi:10.1001/archneur.59.1.123

22. Soukoulis V, Dihu JB, Sole M, et al. "Micronutrient Deficiencies — an Unmet Need in Heart Failure." Journal of the American College of Cardiology. 2009;54(18):1660–1673. doi:10.1016/j.jacc.2009.08.012

23. Xu M, Ji J, Lu Q, et al. "The Effects of Thiamine Supplementation on Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Complementary Therapies in Medicine. 2022;70:102853. doi:10.1016/j.ctim.2022.102853

24. Keith M, Quach S, Ahmed M, et al. "Thiamin Supplementation Does Not Improve Left Ventricular Ejection Fraction in Ambulatory Heart Failure Patients: A Randomized Controlled Trial." The American Journal of Clinical Nutrition. 2019;110(6):1287–1295. doi:10.1093/ajcn/nqz192

25. Chow SL, Bozkurt B, Baker WL, et al. "Complementary and Alternative Medicines in the Management of Heart Failure: AHA Scientific Statement." Circulation. 2023;147(2):e4–e30. doi:10.1161/CIR.0000000000001110

26. Fujii T, Luethi N, Young PJ, et al. "Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial." JAMA. 2020;323(5):423–431. doi:10.1001/jama.2019.22176

27. Moskowitz A, Huang DT, Hou PC, et al. "Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial." JAMA. 2020;324(7):642–650. doi:10.1001/jama.2020.11946

28. Sevransky JE, Rothman RE, Hager DN, et al. "Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial." JAMA. 2021;325(8):742–750. doi:10.1001/jama.2020.24505

29. Woolum JA, Abner EL, Kelly A, et al. "Effect of Thiamine Administration on Lactate Clearance and Mortality in Patients With Septic Shock." Critical Care Medicine. 2018;46(11):1747–1752. doi:10.1097/CCM.0000000000003311

30. Wilson RB. "Pathophysiology, Prevention, and Treatment of Beriberi After Gastric Surgery." Nutrition Reviews. 2020;78(12):1015–1029. doi:10.1093/nutrit/nuaa004